Valuation: Merck KGaA

Market Cap 64.52B 70.82B 59.73B 54.03B 101B 6,614B 106B 722B 286B 3,574B 266B 260B 11,321B P/E 2026 *
25.6x
P/E 2027 * 21.1x
Enterprise Value 71.83B 78.84B 66.49B 60.14B 113B 7,363B 118B 804B 319B 3,979B 296B 290B 12,603B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 3.05x
Free-Float
29.73%
Yield 2026 *
1.59%
Yield 2027 * 1.63%
1 day-0.67%
1 week-1.40%
Current month-2.51%
1 month+0.75%
3 months+6.85%
6 months+20.16%
Current year+20.31%
1 week 147.5
Extreme 147.5
152.35
1 month 141.6
Extreme 141.6
156.25
Current year 100.7
Extreme 100.7
156.25
1 year 100.7
Extreme 100.7
156.25
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 61 01/05/2026
Director of Finance/CFO 56 01/07/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 26/04/2019
Director/Board Member 60 09/05/2014
Director/Board Member 50 28/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
25/03/26 Buy

Chief Executive Officer

3,386 0.0026%
25/03/26 Buy

Chief Financial Officer

4,563 0.0035%
27/03/25 Buy 1,401 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-1.40%+33.36%-8.41% 70.82B
-2.29%-5.34%+28.73%+128.34% 1,204B
-2.04%-5.78%+31.91%+78.34% 643B
-0.86%-3.71%+21.74%+105.02% 501B
-0.11%-1.48%+27.87%+68.12% 378B
-3.61%-9.62%+39.73%+30.53% 327B
+0.65%-4.52%+27.46%+51.87% 285B
+0.77%-4.09%-1.76%+32.69% 270B
-1.14%-6.05%+28.16%+65.35% 237B
-1.45%-0.85%+30.03%+120.72% 207B
Average -1.08%-3.94%+26.72%+67.26% 412B
Weighted average by Cap. -1.44%-4.63%+27.19%+86.51%

Financials

2026 *2027 *
Net sales 21.7B 23.82B 20.09B 18.17B 34.09B 2,225B 35.68B 243B 96.32B 1,202B 89.36B 87.49B 3,808B 22.92B 25.15B 21.21B 19.19B 36B 2,349B 37.68B 256B 102B 1,269B 94.37B 92.39B 4,021B
Net income 2.35B 2.58B 2.18B 1.97B 3.7B 241B 3.87B 26.35B 10.45B 130B 9.7B 9.49B 413B 2.9B 3.19B 2.69B 2.43B 4.56B 298B 4.77B 32.48B 12.89B 161B 11.95B 11.7B 509B
Net Debt 7.31B 8.02B 6.76B 6.12B 11.48B 749B 12.01B 81.77B 32.43B 405B 30.09B 29.46B 1,282B 5.39B 5.91B 4.99B 4.51B 8.46B 552B 8.86B 60.29B 23.92B 298B 22.19B 21.72B 945B
Projected Income Statement - Annual - Merck KGaA
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
61,949
Date Price Change Volume
20/11/26 €147.00 -0.94% 29,461
19/11/26 €148.40 -0.74% 240,481
18/11/26 €149.50 -0.83% 366,217
17/11/26 €150.75 +0.70% 439,798
16/11/26 €149.70 +0.07% 258,209
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Merck KGaA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
148.40EUR
Average target price
159.29EUR
Spread / Average Target
+7.34%